Free Trial

SBC Medical Group (NASDAQ:SBC) Upgraded by Wall Street Zen to Buy Rating

SBC Medical Group logo with Medical background

Key Points

  • SBC Medical Group has been upgraded from a "hold" to a "buy" rating by analysts at Wall Street Zen.
  • The company's shares opened at $4.35 and have a market cap of $451.88 million, with a debt-to-equity ratio of 0.03.
  • SBC Medical Group reported a net margin of 17.71% and a revenue of $43.36 million for its latest quarterly earnings, missing estimates.
  • Interested in SBC Medical Group? Here are five stocks we like better.

SBC Medical Group (NASDAQ:SBC - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Saturday.

SBC Medical Group Stock Down 1.9%

NASDAQ SBC traded down $0.09 during trading on Friday, hitting $4.40. The company's stock had a trading volume of 11,111 shares, compared to its average volume of 67,399. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.98 and a quick ratio of 3.95. SBC Medical Group has a fifty-two week low of $2.62 and a fifty-two week high of $12.50. The company has a market cap of $456.55 million, a PE ratio of 13.73 and a beta of 1.27. The business's 50 day simple moving average is $4.47 and its 200-day simple moving average is $4.14.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last released its earnings results on Wednesday, August 13th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.14 by ($0.12). SBC Medical Group had a return on equity of 20.76% and a net margin of 17.71%.The firm had revenue of $43.36 million for the quarter, compared to analyst estimates of $44.71 million. On average, equities analysts anticipate that SBC Medical Group will post 5.02 EPS for the current fiscal year.

Institutional Investors Weigh In On SBC Medical Group

A number of institutional investors and hedge funds have recently modified their holdings of the company. XTX Topco Ltd acquired a new stake in shares of SBC Medical Group during the second quarter worth about $64,000. New York State Common Retirement Fund acquired a new stake in shares of SBC Medical Group during the second quarter worth about $104,000. SBI Securities Co. Ltd. lifted its holdings in shares of SBC Medical Group by 227.3% during the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock worth $251,000 after purchasing an additional 37,623 shares during the period. Finally, Geode Capital Management LLC purchased a new position in SBC Medical Group during the second quarter valued at approximately $455,000. Institutional investors and hedge funds own 60.82% of the company's stock.

SBC Medical Group Company Profile

(Get Free Report)

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.

Recommended Stories

Should You Invest $1,000 in SBC Medical Group Right Now?

Before you consider SBC Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.

While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.